~~<i id='B76B721272'><strike id='B76B721272'><tt id='B76B721272'><pre id='B76B721272'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：knowledge 2025-09-14 10:06:06 - browse：5478

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Listen: Biogen's messy board & Laronde's data problem

hotspot

focus

hotspot

focus

knowledge

entertainment

0:50AhumpbackwhalebreachesnearSydney,Australia,June24,2023.CourtesyMarkWongJulymarksthepeakofthehump

WSS

Can CDC director Mandy Cohen drive consensus in Washington?

These geoengineering technologies could help combat the climate crisis, scientists say

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Mike Pence clashes with Tucker Carlson in Iowa

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Connecting traumatic brain injury and domestic violence

hotspot

hotspot

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Global childhood vaccinations edge closer to pre

Apple is now the first public company to be valued at $3 trillion

New case study details death in closely watched Alzhiemer's trial

State Dept. review finds Biden bears some blame for Afghanistan failures

Celiac disease study examines precisely how gluten triggers injury

DIEP, the 'gold standard' of breast reconstruction, is under threat

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Novavax promises a turnaround & Lilly roils the obesity market

Global childhood vaccinations edge closer to pre

focus

Meta looks to target Twitter with a rival app called Threads

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Care demand spikes challenge UnitedHealth’s provider arm

7 people shot in DC, police say

Why is France rioting? What to know about the fatal police shooting of Nahel M

These geoengineering technologies could help combat the climate crisis, scientists say

hotspot

focus

knowledge

entertainment